LDS partner Marek
Lazewski took part as an expert in a panel on Interpreting Article 3(d) of The
SPC Regulation: In Search of a New Formulation for a Known Active Ingredient.
This panel discussion was a part of the Pharmaceutical Patent Term Extensions
conference in Munich on June 25-26, 2019.
Further details are available here.